Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The State Scientific Research Institute of Organic Chemistry and Technology (GosNIIOKHT) is a premier Russian federal research institution and manufacturer focused on organic synthesis, chemical safety, and pharmaceuticals. Established in 1924 and based in Moscow, it operates as a Federal State Unitary Enterprise under the Ministry of Industry and Trade. The institute is a critical component of Russia's pharmaceutical infrastructure, specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms for oncology, antiviral treatments, and toxicology. GosNIIOKHT is notably equipped with GMP-compliant facilities and handles the full lifecycle of drug development, from initial R&D to industrial-scale manufacturing. It also plays a leading role in the national program for chemical weapons destruction and the development of specialized medical countermeasures and antidotes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on All-Russian Scientific Research Institute of Organic Chemistry.